Home / Inspections / 1109452

FDA Inspection 1109452 — Aurolife Pharma, LLC

Aurolife Pharma, LLC — FEI 3005796917

The FDA completed an inspection of Aurolife Pharma, LLC on October 22, 2019 in Dayton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 22, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayton, NJ (United States)

Facility

Other inspections at this facility

  • 1158258 (OAI Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1055912 (VAI Thu Jun 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 980107 (NAI Thu Jul 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 952634 (NAI Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 933659 (NAI Thu Jul 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources